| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Current Challenges in Stem Cell Transplantation in Myelofibrosis
|
Kröger, Nicolaus
|
|
2015
|
10 |
4 |
p. 344-350
|
artikel
|
| 2 |
Cutaneous T cell Lymphoma: an Update on Pathogenesis and Systemic Therapy
|
Chung, Catherine G.
|
|
2015
|
10 |
4 |
p. 468-476
|
artikel
|
| 3 |
Immunological Consequences of JAK Inhibition: Friend or Foe?
|
McLornan, Donal P.
|
|
2015
|
10 |
4 |
p. 370-379
|
artikel
|
| 4 |
Immunotherapy for Multiple Myeloma, Past, Present, and Future: Monoclonal Antibodies, Vaccines, and Cellular Therapies
|
Karp Leaf, Rebecca
|
|
2015
|
10 |
4 |
p. 395-404
|
artikel
|
| 5 |
Mature T-cell leukemias: Molecular and Clinical Aspects
|
Bailey, Nathanael G.
|
|
2015
|
10 |
4 |
p. 421-428
|
artikel
|
| 6 |
Molecular Pathogenesis of Peripheral T Cell Lymphoma
|
Sakata-Yanagimoto, Mamiko
|
|
|
10 |
4 |
p. 429-437
|
artikel
|
| 7 |
Molecular Pathogenesis of Peripheral T Cell Lymphoma
|
Sakata-Yanagimoto, Mamiko
|
|
2015
|
10 |
4 |
p. 429-437
|
artikel
|
| 8 |
Novel Induction Regimens in Multiple Myeloma
|
Runcie, Karie D.
|
|
2015
|
10 |
4 |
p. 388-394
|
artikel
|
| 9 |
Oncogenic Drivers in Myeloproliferative Neoplasms: From JAK2 to Calreticulin Mutations
|
Cahu, Xavier
|
|
2015
|
10 |
4 |
p. 335-343
|
artikel
|
| 10 |
Setting Appropriate Goals for the Next Generation of Clinical Trials in Myelofibrosis
|
Barosi, Giovanni
|
|
2015
|
10 |
4 |
p. 362-369
|
artikel
|
| 11 |
Social Media and Myeloproliferative Neoplasms (MPN)—Focus on Twitter and the Development of a Disease-specific Community: #MPNSM
|
Pemmaraju, Naveen
|
|
2015
|
10 |
4 |
p. 413-420
|
artikel
|
| 12 |
Social Media and the Practicing Hematologist: Twitter 101 for the Busy Healthcare Provider
|
Thompson, Michael A.
|
|
2015
|
10 |
4 |
p. 405-412
|
artikel
|
| 13 |
Targets, Toxins, and T Cells—a Review of New Monoclonal Antibodies in the Treatment of Peripheral T Cell Lymphomas
|
Hebb, Jonathan
|
|
|
10 |
4 |
p. 438-447
|
artikel
|
| 14 |
Targets, Toxins, and T Cells—a Review of New Monoclonal Antibodies in the Treatment of Peripheral T Cell Lymphomas
|
Hebb, Jonathan
|
|
2015
|
10 |
4 |
p. 438-447
|
artikel
|
| 15 |
The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment
|
Gru, A. A.
|
|
2015
|
10 |
4 |
p. 456-467
|
artikel
|
| 16 |
The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell Project
|
Bellei, Monica
|
|
2015
|
10 |
4 |
p. 448-455
|
artikel
|
| 17 |
Tyrosine Kinase Inhibitors and Therapeutic Antibodies in Advanced Eosinophilic Disorders and Systemic Mastocytosis
|
Gotlib, Jason
|
|
2015
|
10 |
4 |
p. 351-361
|
artikel
|
| 18 |
What Do Molecular Tests Add to Prognostic Stratification in MF: Is It Time to Add These to Our Clinical Practice?
|
Guglielmelli, Paola
|
|
2015
|
10 |
4 |
p. 380-387
|
artikel
|
Tijdschrift beschrijving